ADIL - Adial Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $0.29. This is a potential upside of $-0.33 (-53.23%) from yesterday's end of day stock price of $0.62.

Adial Pharmaceuticals's activity chart (see below) currently has 0 price targets and 2 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 384.33 days.

Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 17-Aug-2022. First documented stock forecast 29-Jun-2021.

Best performing analysts who are covering ADIL - Adial Pharmaceuticals:

Theodore O'neill Kumaraguru Raja Jason Mccarthy

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$5

2 years 8 months 22 days ago
(17-Aug-2022)

1/1 (100%)

$-15.84 (-76.01%)

384

Buy

$12

$9.22 (331.65%)

3 years 6 months 25 days ago
(14-Oct-2021)

0/1 (0%)

$8.01 (200.75%)

Buy

$15

$12.22 (439.57%)

$5

3 years 8 months 13 days ago
(26-Aug-2021)

1/2 (50%)

$6.85 (199.04%)

769

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ADIL (Adial Pharmaceuticals) average time for price targets to be met?

On average it took 384.33 days on average for the stock forecasts to be realized with a an average price target met ratio 50

Which analyst has the current highest performing score on ADIL (Adial Pharmaceuticals) with a proven track record?

THEODORE O'NEILL

Which analyst has the current lower performing score on ADIL (Adial Pharmaceuticals) with a proven track record?

JASON MCCARTHY

Which analyst has the most public recommendations on ADIL (Adial Pharmaceuticals)?

Theodore O'neill works at ASCENDIANT and has 3 price targets and 2 ratings on ADIL

Which analyst is the currently most bullish on ADIL (Adial Pharmaceuticals)?

Theodore O'neill with highest potential upside - $12.22

Which analyst is the currently most reserved on ADIL (Adial Pharmaceuticals)?

Jason Mccarthy with lowest potential downside - -$0

Adial Pharmaceuticals in the News

Adial Pharmaceuticals Announces a Warrant Inducement Transaction for $2.75 Million in Gross Proceeds

GLEN ALLEN, Va., May 02, 2025 (GLOBE NEWSWIRE) —  Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced its entry into a warrant inducement agreement with an existing healthcare-focused institutional investor of the Company for...

Adial Pharmaceuticals Expands Intellectual Property Portfolio with New U.S. Patent Granted for Genetic-Based Treatment of Alcohol and Opioid Use Disorders

GLEN ALLEN, Va., May 01, 2025 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced patent number 12,274,692 was issued on April 15, 2025 by the United States Patent and Trademark Office...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?